Indianapolis, IN, United States of America

Anthony John Shuker


Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 86(Granted Patents)


Location History:

  • Atlanta, GA (US) (2001 - 2004)
  • Indianapolis, IN (US) (1998 - 2006)

Company Filing History:


Years Active: 1998-2006

Loading Chart...
18 patents (USPTO):Explore Patents

Title: Anthony John Shuker: Innovator in Diabetes and Obesity Treatment

Introduction

Anthony John Shuker is a prominent inventor based in Indianapolis, IN, known for his significant contributions to the medical field. With a remarkable portfolio of 18 patents, his work primarily focuses on the treatment of Type II diabetes and obesity. His innovative approaches and compounds provide unique solutions for improving health outcomes in these critical areas.

Latest Patents

One of Anthony John Shuker's latest patents addresses the treatment of Type II diabetes and obesity through selective β receptor agonists. This invention presents novel compounds and methods for administering these compounds to mammals in need, aiming to effectively combat the challenges posed by these health conditions. Additionally, his patent on modulators of peroxisome proliferator-activated receptors demonstrates his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Anthony has worked with several esteemed organizations, including Eli Lilly and Company. His tenure in the pharmaceutical industry has allowed him to develop and refine his innovative ideas, leading to the creation of impactful medical solutions.

Collaborations

In his professional journey, Anthony has collaborated with notable colleagues, including Christopher J. Rito and Thomas Alan Crowell. These partnerships have paved the way for breakthroughs in medical research and development, fortifying his contributions to the field.

Conclusion

Anthony John Shuker's dedication to innovation in the medical realm is evident in his numerous patents and collaborative efforts. His work continues to shape the landscape of treatments for Type II diabetes and obesity, establishing him as a key figure in the fight against these prevalent health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…